Pharmaceuticals: North America (NAFTA) Industry Guide

Date: May 9, 2014
Pages: 90
Price:
US$ 795.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PA2263FE3C5EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals: North America (NAFTA) Industry Guide
The NAFTA Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players' NAFTA operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA pharmaceuticals market with five year forecasts
  • Compares data from the US, Canada and Mexico, alongside individual chapters on each country
Highlights

The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The pharmaceuticals industry within the NAFTA countries had a total market value of $321.9 billion in 2013.The Mexico was the fastest growing country, with a CAGR of 7% over the 2009-13 period.

Within the pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $284.6 billion in 2013. This was followed by Canada and Mexico, with a value of $22.9 and $14.4 billion, respectively.

The US is expected to lead the pharmaceuticals industry in the NAFTA bloc, with a value of $344.0 billion in 2018, followed by Canada and Mexico with expected values of $27.3 and $19.8 billion, respectively.

Your key questions answered
  • What was the size of the NAFTA pharmaceuticals market by value in 2013?
  • What will be the size of the NAFTA pharmaceuticals market in 2018?
  • What factors are affecting the strength of competition in the NAFTA pharmaceuticals market?
  • How has the market performed over the last five years?
INTRODUCTION

What is this report about?
Who is the target reader?
How to use this report
Definitions

NAFTA PHARMACEUTICALS

Industry Outlook

PHARMACEUTICALS IN CANADA

Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators

PHARMACEUTICALS IN MEXICO

Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators

PHARMACEUTICALS IN THE UNITED STATES

Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators

APPENDIX

Methodology

Ask Your Question

Pharmaceuticals: North America (NAFTA) Industry Guide
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: